Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Autonomix Medical Inc
AMIX
Healthcare
Medical Devices
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and...
addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:AMIX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
Next
(1384)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 09, 2026 12:26pm
AMIX....this piece of &%$# !!!!!
My past experience with this proved to me that this is a typical NASDAQ Shitco that uses Pre-market & After Hours trading to their advantage....which is to avoid Retail completely Today
...more
(187)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Nov 17, 2025 8:45am
Buy buddy buy because it's taking off this morning.time
Otherwise it will be FOMO time for you fellas out there today anyway
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 24, 2025 9:00am
New Press Release - Autonomix Medical, Inc. Featured in Two Innovation in Interventional Cardiology Podium Presentations at the Transcatheter Cardiovascular Therapeutics® (TCT®) Annual Scientific Conference
THE WOODLANDS, TX, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced it will be featured in two podium presentations at the Transcatheter...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 16, 2025 9:15am
New Press Release - Autonomix Medical, Inc. to Highlight Innovative Nerve-Sensing and Ablation Platform at the 2025 Maxim Growth Summit
THE WOODLANDS, TX, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced it will participate at the 2025 Maxim Growth Summit, taking place...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 09, 2025 8:45am
New Press Release - Autonomix Medical, Inc. Granted U.S. Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology
With over 120 issued and pending patent applications, Autonomix is building a comprehensive, global IP portfolio in nerve-sensing and modulationNewly issued patent strengthens the Company’s strategic position in a multi-billion-dollar market opportunity and unlocking potential across...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 02, 2025 8:45am
New Press Release - Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment
THE WOODLANDS, TX, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced the next CEO Corner segment has been published on the Company’s website....
read article.
(1384)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 29, 2025 9:26am
AMIX....On watch....NR this a.m
Read the NR
(0)
•••
PressRelease
X
Post by
PressRelease
on Sep 29, 2025 9:15am
New Press Release - Autonomix Medical, Inc. Initiates Good Laboratory Practice (GLP) Study for Sensing and RF Ablation System
GLP study marks a key milestone in Autonomix's path to achieve regulatory approvalsCompany remains on track to submit Investigational Device Exemption (“IDE”), and if approved, commence U.S. clinical trials in 2026 to support a De Novo FDA application THE WOODLANDS, TX, Sept. 29, 2025 (GLOBE...
read article.
(1384)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 17, 2025 4:20pm
AMIX.....sold all
No position Lo Siento Amigos !
(1384)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 17, 2025 4:19pm
AMIX.....I forgot that there will be a AGM on Oct 30
voting on these proposals..... you be the judge. https://www.sec.gov/Archives/edgar/data/1617867/000143774925028954/amix20250831_def14a.htm
(1384)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 17, 2025 4:10pm
AMIX....big volume increase during AH trading
Just might be "The Next One" to rally big-time Buckle up.....could be big ; ) JMHO
(1384)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 17, 2025 4:03pm
AMIX....up in AH Trading....Yeeha$1.35 now
LFG
(1384)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 15, 2025 2:07pm
AMIX.....currently trading at $1.12
Make note : AGM Date..... Autonomix Medical, Inc. has announced its Annual Meeting on 10/30/2025 at 10:00 AM, Local Time.
(0)
•••
PressRelease
X
Post by
PressRelease
on Sep 09, 2025 9:00am
New Press Release - Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2025 CIRSE Annual Congress
Presentation to highlight findings from the first phase of the Company’s ongoing first-in-human proof-of-concept (PoC) clinical trial THE WOODLANDS, TX, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Sep 04, 2025 9:00am
New Press Release - Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor "What This Means" Segment
Dr. Robert Schwartz, Chief Medical Officer of Autonomix, discusses the Company’s recently announced results from the post hoc analysis of its proof-of-concept human clinical trial (“PoC 1”) THE WOODLANDS, TX, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix...
read article.
Prev
1
2
3
4
5
6
7
8
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
Western Star Resources Expands Its Past Producing Rowland Tungsten Property by 170%
Airborne geophysical survey commences at Haldane Silver Project at Keno Hill Silver District, Yukon
Podcasts